Turn this list into pipeline.
Pharmaceutical Companies in Bristol: 61 Active Firms (2026)
Pharmaceutical companies in Bristol develop, manufacture or distribute regulated medicines across the city and its surrounding metropolitan area.
Buying centres tend to sit in quality, regulatory affairs, clinical operations, procurement and medical-supply functions, rather than a unified commercial buyer. Bristol suppliers usually sell into healthcare providers, clinical-research channels, wholesalers, public-healthcare supply routes and export-facing distributors, with decision cycles shaped by validation and audit trails. Engagements are rarely casual spot purchases: even distribution work depends on documented quality controls, while manufacturing or import relationships carry licence, batch-release and pharmacovigilance obligations. The practical buyer is often a cross-functional group that cares as much about compliance evidence and continuity of supply as price.
Read more
Bristol has 61 actively trading pharmaceutical companies in this cohort, giving the city a small, specialist base rather than a broad national hub. 5 have turnover above £5M, while 18 were incorporated since 2022, so the list mixes established regulated operators with a newer tail. Among those with headcount filings, 19 of 19 report staff, with total reported headcount of 323. That footprint suggests a market led by specialist teams and a limited set of larger operating businesses, rather than many large-scale local manufacturers.
Human medicines sit under MHRA oversight from clinical-trial approval through licensing, pharmacovigilance and manufacturing inspection. Manufacturers, assemblers and importers need the relevant licence and must maintain good manufacturing practice, while wholesale supply requires licensing and good distribution practice. Medicines also need marketing authorisation before sale, and public-healthcare access tends to bring health-technology assessment into the commercial timetable. The ABPI provides the main research-based industry voice for this part of the market. For Bristol firms, that structure makes regulatory capability part of the product proposition, not just a back-office control.
The Bristol cohort appears weighted towards specialist operators rather than large integrated campuses, so expansion is likely to depend on regulated service depth, distribution reach and clinical-supply relationships. Manufacturing and distribution firms tend to be constrained by licensing, inspection and quality-assurance capacity, while research-led suppliers carry longer validation and reimbursement cycles. That points to selective expansion rather than a broad local surge. Firms with embedded quality systems and export permissions may find more routes to contract work, but new entrants face material fixed compliance costs. Consolidation remains plausible where licence holders, wholesalers and service providers can reduce duplicated regulatory overhead.
61
Active firms
2026
5
Over £5M
companies by revenue
18
Incorporated since 2022
new incorporations
Key facts
About 8% of the trading cohort reports turnover above £5M (5 of 61 firms) — the rest sits below that revenue band.
29% of the cohort was incorporated since 2022 (18 firms), so a sizeable share is in its first few filing cycles.
UK human medicines are regulated by the MHRA, covering standards, clinical-trial approvals, medicine licensing and pharmacovigilance.
Manufacturers, assemblers and importers of human medicines need an MHRA manufacturer’s licence, good manufacturing practice compliance and regular site inspections.
Wholesale supply to anyone other than the patient requires a wholesale distribution licence and good distribution practice compliance.
Pharmaceutical R&D performed by UK businesses reached £9.0 billion in 2022, equivalent to 0.36% of UK GDP and 18% of all UK business R&D.
UK pharmaceutical exports were valued at £25.6 billion in 2023, with the UK ranked tenth among comparator countries.
Top Bristol pharmaceutical companies
MILTON PHARMACEUTICAL COMPANY UK LIMITED
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsProvides pharmaceutical development and manufacturing services, including preformulation and formulation development, analytical testing, clinical trial manufacturing for Phase I–III, commercial…
Serves pharmaceutical and biotechnology companies developing medicines from preclinical to commercial stages, including clinical trial sponsors and firms working on orphan drugs, specials and live…
Financial Health
HealthyHealthy · Growing · 0% CAGR over 3y
Location
A-Tek Pharma Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies and distributes pharmaceutical products including generic medicines, over-the-counter drugs, vaccines, vitamins and minerals, topical creams, and aesthetic injectables. Provides…
Serves pharmacies, GPs, registered medical professionals and aesthetics or dental practices seeking pharmaceutical supply in UK and export markets.
Financial Health
WeakWeak
Location
Provides contract research, development and manufacturing services for the pharmaceutical industry. Supports drug discovery, process development and GMP production of small molecules, biologics,…
Serves pharmaceutical, biotech and life sciences companies developing small-molecule, biologic, sterile drug and generic API products, from early discovery teams to clinical and commercial…
Location
Bipsco Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies pharmaceutical products to independent pharmacies and retailers, including generic medicines, over‑the‑counter treatments and toiletries. Operates as a wholesale distributor providing…
Serves independent pharmacists, retail shops and homecare institutions in the South West of the UK, targeting local B2B healthcare and retail customers.
Financial Health
StrongStrong · Hiring · 14% CAGR over 4y
Location
ZYDUS PHARMACEUTICALS UK LTD
Trajectory
2y · 2023–NowDevelops, manufactures, and markets pharmaceutical medicines and healthcare products. Conducts research and development, supplies prescription drugs, and provides medical information and adverse…
Serves healthcare-sector buyers in the UK pharmaceutical market, including organisations involved in prescribing, dispensing, distributing or procuring medicines, with product and medical information…
Financial Health
Insufficient historyInsufficient history
Location
Provides contract research, drug discovery, development and manufacturing services for pharmaceutical companies. Activities include medicinal chemistry, biologics and antibody development, API and…
Serves biopharma and pharmaceutical companies needing outsourced drug discovery, development and manufacturing support. Targets R&D, CMC and production teams across small molecules, biologics,…
Location
Pharmedics Ltd
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StableStable
Location
REENA ENTERPRISES LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsProvides analytical laboratory testing, regulatory affairs support and contract manufacturing services for pharmaceutical, natural health product, cosmetics, personal care and food and beverage…
Serves B2B brands and manufacturers in natural health products, pharmaceuticals, cosmetics, personal care, food and beverage, medical devices, and cannabis/CBD markets.
Financial Health
StableStable · Hiring · 5% CAGR over 4y
Location
Red Label Medical Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsOperates an online pharmacy providing remote consultations and prescription medicines for conditions such as acne, erectile dysfunction, weight loss, infections and menopause. Dispenses and delivers…
Serves UK consumers and patients seeking online access to prescription and pharmacy treatments across men’s health, women’s health, skin, pain, weight loss, sexual health and common conditions.
Financial Health
HealthyHealthy
Location
Shaunaks Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsFinancial Health
StableStable · 0% CAGR over 2y
Location
Trajectory
2y · 2020–NowFinancial sub-scores
Computed from 2 filingsSupplies injectable medicines, analgesics and drug solutions, including pre‑filled syringe products, to hospitals and healthcare providers. Supports medication delivery and safety for clinical use…
Serves NHS and Irish healthcare organisations, primarily hospitals and healthcare professionals needing hospital medicines for patient care across the UK and Ireland.
Financial Health
HealthyHealthy · Growing · 0% CAGR over 1y
Location
R&d Pharmaceuticals Ltd
Trajectory
1y · 2024–NowDevelops and manufactures pharmaceutical medicines and vaccines. Conducts analytical and chemical research and development, drug product design, quality assurance, and regulatory affairs activities…
Serves healthcare professionals, patients and healthcare systems requiring access to approved medicines and vaccines, with an emphasis on European and international regulated markets.
Financial Health
Insufficient historyInsufficient history
Location
MARIA-CRISTINA CULITA LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StableStable · 0% CAGR over 4y
Location
VirTus Respiratory Research Limited
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsProvides contract research services for respiratory drug development, including preclinical in vitro and in vivo studies, human viral challenge trials, and clinical trial management for…
Serves multinational pharmaceutical companies and small biotech enterprises developing respiratory medicines, vaccines, antivirals and immunomodulatory drugs, especially teams needing preclinical or…
Financial Health
StrongStrong · Growing, Hiring · 33% CAGR over 3y
Location
Pill Time Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides online pharmacy services, dispensing and delivering NHS prescriptions in pre‑sorted, labelled medication pouches. Offers an app for prescription management, reminders, and delivery tracking,…
Serves UK consumers and NHS patients who need regular prescription medication support, plus adults seeking online weight-loss treatment and carers managing medicines for family members or dependants.
Financial Health
WeakWeak · Hiring · 4% CAGR over 4y
Location
Layanson Pharma Ltd
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
HealthyHealthy · Profitable, Hiring · 90% CAGR over 1y
Location
Locking Pharmacy Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
HealthyHealthy · -6% CAGR over 4y
Location
Layade Pharma Ltd
Trajectory
1y · 2025–NowFinancial Health
Insufficient historyInsufficient history
Location
Unlock all 61 leads
Showing 18 of 61 — +43 more with verified decision-maker contacts, live data, and CRM sync.
How Bristol pharmaceutical companies work and how to sell to them
What they do
Bristol pharmaceutical firms earn revenue through a mix of product sales, wholesale margin, contract manufacturing, import and assembly fees, clinical-supply services, and regulatory or quality-led support work. Prices are usually tied to batch volume, licence scope, storage and handling requirements, and the amount of validation needed before a customer can switch supplier. Compared with general industrial suppliers, the commercial unit is less often a simple project day-rate and more often a controlled supply relationship: audited sites, release documentation, cold-chain evidence, complaint handling and repeat ordering all sit inside the margin.
Who they sell to
Most sell to hospital procurement teams, pharmacy wholesalers, clinical-research organisations, public-healthcare buyers, specialist distributors and larger life-sciences groups that need local supply, batch handling or outsourced regulated capacity. The buyer group typically includes quality assurance, regulatory affairs, responsible-person functions, procurement, clinical operations and finance, with senior approval where supply risk or patient exposure is high. Smaller catalogue or distribution relationships can move through direct sales and framework purchasing, but manufacturing, import or clinical-supply work tends to involve audits, technical questionnaires, sample runs and contract reviews before commercial terms are settled.
What they buy
Most Bristol pharmaceutical firms tend to spend on systems and services that protect licence status and customer trust: quality management software, document control, electronic batch records, pharmacovigilance workflow, supplier qualification, audit management, temperature monitoring and traceability. They also buy specialist legal and regulatory advice, validation support, insurance, warehousing, cold-chain logistics, laboratory services, finance and payroll support, and recruitment for quality, regulatory, production and commercial roles. Firms with export-facing or public-healthcare routes may also need tender support, market-access advice, translation, customs expertise and customer onboarding processes that preserve evidence for later inspection.
Why and how to sell to them
Buying intent often appears when a firm is preparing for inspection, adding a licence activity, taking on a new distribution route, moving from ad hoc clinical supply into repeat contracts, or hiring into quality and regulatory teams. Sellers usually need to foreground risk reduction and audit evidence rather than general productivity claims. Useful outreach cites the buyer’s operating model: batch documentation for manufacturers, temperature and traceability controls for distributors, pharmacovigilance workflow for authorised products, or tender discipline for public-healthcare channels. Short proof cycles, implementation burden and validation support matter because switching itself can create compliance work.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in Bristol
Related directories
Frequently asked questions
How many pharmaceutical companies are there in the Bristol?↓
What counts as a pharmaceutical company in this list?↓
Which are the largest pharmaceutical companies in the Bristol?↓
What do pharmaceutical companies in the Bristol actually do?↓
How does Bristol pharmaceutical compare internationally?↓
How is this list built and how fresh is the data?↓
How big are the typical pharmaceutical companies in the Bristol?↓
Are these mostly new or established pharmaceutical companies?↓
What SIC codes does this use?↓
What buying signals should I look for?↓
Push these 61 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.